☆ 4.8 Editorial Material

Interplay between hepatitis B virus and TLR2-mediated innate immune responses: Can restoration of TLR2 functions be a new therapeutic option?

JOURNAL OF HEPATOLOGY (2012)

期刊

JOURNAL OF HEPATOLOGY

卷 57, 期 3, 页码 486-489

出版社

ELSEVIER SCIENCE BV

DOI: 10.1016/j.jhep.2012.06.019

关键词

类别

Gastroenterology & Hepatology

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

主要评分

4.8

评分不足

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

Interplay between nuclear factor-KB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells

Akanksha Bansal, Mahmoud M. Mostafa, Cora Kooi, Sarah K. Sasse, Aubrey N. Michi, Suharsh Shah, Richard Leigh, Anthony N. Gerber, Robert Newton

Summary: This study investigates the synergy between synthetic glucocorticoids and proinflammatory cytokines on the expression of TLR2 gene, and identifies specific enhancer regions and the regulation of p38a MAPK in this process.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

添加到收藏夹

Article Immunology

Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B

Steffen Wildum, Kyle E. Korolowicz, Manasa Suresh, Guido Steiner, Lue Dai, Bin Li, Changsuek Yon, Maria Cristina De Vera Mudry, Franziska Regenass-Lechner, Xu Huang, Xupeng Hong, Marta G. Murreddu, Bhaskar V. Kallakury, John A. T. Young, Stephan Menne

Summary: RG7854 shows potential for treating chronic hepatitis B in woodchucks, suppressing viral replication, inducing immune responses, and producing sustained antiviral effects. Combination treatment with entecavir does not enhance the therapeutic efficacy of RG7854, but augments the magnitude of immune responses.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Veterinary Sciences

Interplay between swine enteric coronaviruses and host innate immune

Mingwei Li, Longjun Guo, Li Feng

Summary: Swine enteric coronavirus causes severe losses in neonatal piglets worldwide. Mixed infections with different members of the virus pose a threat to public health and global security. Studies focus on the effects of viral proteins on apoptosis, autophagy, and innate immunity.

FRONTIERS IN VETERINARY SCIENCE (2022)

添加到收藏夹

Review Immunology

Hepatitis B functional cure and immune response

Jia-Rui Zheng, Zi-Long Wang, Bo Feng

Summary: Hepatitis B virus infection causes indirect damage to hepatocytes through the immune system. The exhaustion of virus-specific immune cells and immune suppression by virus antigens contribute to the chronicity of the infection. Functional cure can be achieved by restoring the specific immune function, providing a theoretical basis for complete cure of hepatitis B.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Functions of TRIM56 in Antiviral Innate Immunity and Tumorigenesis

Lin Fu, Xiaotong Zhou, Qian Jiao, Xi Chen

Summary: As a member of the TRIM protein family, TRIM56 acts as an E3 ubiquitin ligase and exhibits deubiquitinase activity and RNA binding ability. Its role in innate immune response regulation, antiviral defense, and tumor development has attracted attention from researchers. However, there is a lack of systematic review on TRIM56.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications

Alice Indini, Francesco Grossi, Mario Mandala, Daniela Taverna, Valentina Audrito

Summary: Malignant melanoma, the most fatal skin cancer, has seen a shift in treatment strategies with the introduction of new inhibitors and immunotherapy. However, resistance to systemic treatments remains a challenge, driven by various mechanisms involving cancer metabolism, epigenetics, gene expression, and interactions within the tumor microenvironment. Biomarkers are needed to guide patient selection and treatment decisions.

BIOMEDICINES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Endothelial TLR2 promotes proangiogenic immune cell recruitment and tumor angiogenesis

Michael G. McCoy, Daniel W. Nascimento, Manoj Veleeparambil, Rakhylia Murtazina, Detao Gao, Svyatoslav Tkachenko, Eugene Podrez, Tatiana Byzova

Summary: TLR2 plays a crucial role in endothelial cells, promoting inflammatory responses, tumor growth, and angiogenesis. Studies have shown that endothelial cells lacking TLR2 have reduced anti-inflammatory capabilities, potentially contributing to disease progression.

SCIENCE SIGNALING (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

The emerging roles and therapeutic potential of B cells in sepsis

Chengyong Ma, Hanrui Liu, Shuo Yang, Hong Li, Xuelian Liao, Yan Kang

Summary: Sepsis is a life-threatening syndrome caused by abnormal host response to infection. Immune dysfunction is central to its occurrence and development. Dysfunction of B cells in sepsis is linked to immune derangement mechanisms.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Interplay between Hepatitis E Virus and Host Cell Pattern Recognition Receptors

Pradip Devhare, Mridula Madiyal, Chiranjay Mukhopadhyay, Shiran Shetty, Shamee Shastry

Summary: HEV infection can lead to high mortality in pregnant women and chronic disease in immunocompromised individuals. Extrahepatic manifestations like neuronal and renal diseases can also occur during HEV infection, but the mechanism of pathogenesis is poorly understood.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Review Medicine, General & Internal

Metformin may be a viable adjunctive therapeutic option to potentially enhance immune reconstitution in HIV-positive immunological non-responders

Silvere D. Zaongo, Yaokai Chen

Summary: Incomplete immune reconstitution is a global challenge in HIV treatment, especially for immunological non-responders (INRs). This review provides an overview of the concept of immunological non-response in ART-treated HIV-positive individuals and explains the known mechanisms behind it. Immune cell exhaustion, chronic inflammation, and HIV-associated dysbiosis syndrome are found to contribute to incomplete immune recovery. Metformin, with its properties that target immune cell exhaustion, chronic inflammation, and gut dysbiosis, shows potential as an adjunctive treatment to enhance immune reconstitution in INRs.

CHINESE MEDICAL JOURNAL (2023)

添加到收藏夹

Article Hematology

Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML

Joshua Bennett, Chiharu Ishikawa, Puneet Agarwal, Jennifer Yeung, Avery Sampson, Emma Uible, Eric Vick, Lyndsey C. Bolanos, Kathleen Hueneman, Mark Wunderlich, Amal Kolt, Kwangmin Choi, Andrew Volk, Kenneth D. Greis, Jan Rosenbaum, Scott B. Hoyt, Craig J. Thomas, Daniel T. Starczynowski

Summary: This study reveals the functional compensation and complementation of IRAK1 in leukemic cells upon inhibition of IRAK4. Cotargeting IRAK1 and IRAK4 is necessary to suppress leukemic stem/progenitor cell function and induce differentiation. IRAK1 and IRAK4 maintain the undifferentiated state of MDS/AML LSPCs through noncanonical MyD88-independent pathways.

BLOOD (2023)

添加到收藏夹

Review Microbiology

The Interplay between Salmonella and Intestinal Innate Immune Cells in Chickens

Adil Ijaz, Edwin J. A. Veldhuizen, Femke Broere, Victor P. M. G. Rutten, Christine A. Jansen

Summary: Salmonellosis is a common infection in poultry that causes economic losses and poses a threat to public health. Antibiotics as feed additives have been effective, but due to resistance issues, alternative strategies such as enhancing innate immunity in young chickens are being explored. Identifying key players in the innate immune response in the intestine is crucial for designing targeted immune modulation approaches.

PATHOGENS (2021)

添加到收藏夹

Review Immunology

Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects

Lilin Wan, Wenchao Li, Yuan Meng, Yue Hou, Ming Chen, Bin Xu

Summary: This review summarizes the roles and regulatory mechanisms of functional enhancers and enhancer RNAs (eRNAs) in inflammatory immune cells, non-inflammatory immune cells, inflammatory immune diseases, and tumors, and explores the potential therapeutic effects of enhancer inhibitors affecting eRNA production for diseases with inflammatory immune responses.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Immunology

Protein O-GlcNAcylation in multiple immune cells and its therapeutic potential

Huanhuan Cai, Wei Xiong, Haoyan Zhu, Qiongxin Wang, Shi Liu, Zhibing Lu

Summary: O-GlcNAcylation is a protein post-translational modification that adds O-GlcNAc to serine or threonine residues of nuclear or cytoplasmic proteins, catalyzed by O-GlcNAc transferase (OGT). This modification plays a critical role in regulating immune cell function and is involved in various physiological and pathophysiological processes. However, the exact role of O-GlcNAcylation in the immune system requires further elucidation. This review provides a comprehensive overview of the current research on protein O-GlcNAcylation, emphasizing the molecular mechanisms that control immune cell growth, maturation, and performance through this post-translational modification.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

Fighting fire with fire: The immune system might be key in our fight against Alzheimer's disease

Pieter Dujardin, Roosmarijn E. Vandenbroucke, Lien Van Hoecke

Summary: The ultimate cause of Alzheimer's disease (AD) is still unknown, but the immune system plays a key role in its pathogenesis. Immunotherapy holds promise as a novel therapy for treating AD, but further research is needed to understand the interaction between AD and the different parts of our immune system.

DRUG DISCOVERY TODAY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Sequence characterization of extracellular HBV RNA in patient plasma

Silvia Chang, Charlotte Hedskog, Bandita Parhy, Ross Martin, Hongmei Mo, Evguenia Maiorova, Fabien Zoulim

Summary: Antiviral nucleos(t)ide analogue therapies can inhibit HBV replication and reduce HBV DNA levels, but HBV RNA levels may remain high. HBV RNA can be used as a viral biomarker for treatment outcome and disease progression. This study characterized the sequence of extracellular HBV RNA in plasma samples of patients with chronic HBV infection, and found that it closely resembles HBV DNA sequence. Additionally, RNA splice forms, different polyA tails start positions, and HBV-human chimeric transcript were identified.

JOURNAL OF VIRAL HEPATITIS (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

The scientific basis of combination therapy for chronic hepatitis B functional cure

Seng Gee Lim, Thomas F. Baumert, Carolina Boni, Ed Gane, Massimo Levrero, Anna S. Lok, Mala K. Maini, Norah A. Terrault, Fabien Zoulim

Summary: Functional cure of chronic hepatitis B (CHB), achieved through hepatitis B surface antigen (HBsAg) loss after 24 weeks off therapy, is the goal of current treatment. However, the rarity of achieving this cure with current therapy highlights the need for novel approaches. The three categories of treatment include reducing viral replication, reducing antigen load, and immunotherapies. Combination therapy of nucleos(t)ide analogues and immunotherapy shows promise in reducing HBsAg levels and inducing HBsAg loss in some patients, particularly those with low baseline HBsAg levels. Monitoring during therapy using viral and immunological biomarkers is important to predict HBsAg loss and understand its mechanisms.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

添加到收藏夹

Review Virology

Heparanase-1: From Cancer Biology to a Future Antiviral Target

Nadjet Lebsir, Fabien Zoulim, Boyan Grigorov

Summary: Heparanase-1 is an important enzyme involved in viral infections and cancer, and its inhibitors can be used as both anti-cancer drugs and antiviral agents, potentially solving drug resistance issues in current antiretroviral therapies.

VIRUSES-BASEL (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

A 3-year course of bulevirtide monotherapy may cure HDV infection in patients with cirrhosis

Maria Paola Anolli, Elisabetta Degasperi, Lena Allweiss, Angelo Sangiovanni, Marco Maggioni, Caroline Scholtes, Valerie Oberhardt, Christoph Neumann-Haefelin, Maura Dandri, Fabien Zoulim, Pietro Lampertico

Summary: Bulevirtide has received conditional approval from the EMA for treating chronic hepatitis delta, but the optimal duration of therapy remains unknown. In this study, a patient with compensated cirrhosis and esophageal varices achieved hepatitis delta cure after 3 years of bulevirtide monotherapy. Virological and biochemical responses were maintained during the 72-week off-therapy follow-up, and significant improvements were observed in liver biopsy results.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Article Virology

Improved hepatitis delta virus genome characterization by single molecule full-length genome sequencing combined with VIRiONT pipeline

Caroline Charre, Hadrien Regue, Paul Deny, Laurence Josset, Isabelle Chemin, Fabien Zoulim, Caroline Scholtes

Summary: This study presents a workflow to amplify, sequence, and analyze the whole HDV genome in a single fragment. The HDV genome was successfully amplified and fully sequenced, allowing accurate subtyping and identification of a new HDV genotype 1 subtype. This workflow overcomes genome assembly issues and helps to identify modifications throughout the whole HDV genome.

JOURNAL OF MEDICAL VIROLOGY (2023)

添加到收藏夹

Article Physiology

Assessment of neutrophil subsets and immune checkpoint inhibitor expressions on T lymphocytes in liver transplantation: A preliminary study beyond the neutrophil-lymphocyte ratio

Arnaud Riff, Muzhda Haem Rahimi, Marie-Charlotte Delignette, Morgane Gossez, Remy Coudereau, Solene Pantel, Teresa Antonini, Francois Villeret, Fabien Zoulim, Jean-Yves Mabrut, Jerome Dumortier, Fabienne Venet, Fanny Lebosse, Guillaume Monneret

Summary: This study found that the phenotypes of neutrophils and lymphocytes, along with the expression of immune checkpoint proteins, were altered in cirrhotic patients before and after liver transplantation. These findings highlight the potential importance of immune monitoring in cirrhotic patients during liver transplantation to better assess the risk of infection.

FRONTIERS IN PHYSIOLOGY (2023)

添加到收藏夹

Article Endocrinology & Metabolism

Comparison of Pathway Referrals for Liver Fibrosis Risk Stratification Performed in Diabetology and Nutrition Clinics

Cyrielle Caussy, Charlene Telliam, Bader Al-Nuaimi, Marianne Maynard-Muet, Jerome Dumortier, Fabien Zoulim, Emmanuel Disse, Cyrille Colin, Massimo Levrero, Philippe Moulin

Summary: A pathway-referral using transient elastography (TE) performed in diabetology and nutrition clinics significantly improves the liver fibrosis risk stratification and avoids over-referral. However, collaboration between diabetologists, nutritionists, and hepatologists is needed to avoid under-referral.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis

Francois Vileret, Fanny Lebosse, Sylvie Radenne, Didier Samuel, Bruno Roche, Jean-Yves Mabrut, Vincent Leroy, Georges-Philippe Pageaux, Rodolphe Anty, Sylvie Thevenon, Sinafa Si Ahmed, Aaron Hamilton, Marintha Heil, Caroline Scholtes, Massimo Levrero, Barbara Testoni, Fabien Zoulim, ECOGREFFE Study Grp

Summary: This study found that viral recurrence can occur rapidly after liver transplantation, despite prophylaxis with nucleos(t)ide analogues (NUCs) and hepatitis B immunoglobulin (HBIG). The majority of patients had at least one HBV marker detected in either serum or the liver 12 months after transplantation. Optimal patient compliance to antiviral prophylaxis is crucial to prevent viral rebound.

JHEP REPORTS (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study

Thierry Verbinnen, Willem Talloen, Harry L. A. Janssen, Fabien Zoulim, Umesh Shukla, Joris J. Vandenbossche, Michael Biermer, Sandra De Meyer, Oliver Lenz

Summary: The study investigates the viral mutations in patients with hepatitis B virus infection treated with JNJ-56136379. The results demonstrate that viral breakthroughs and emergence of drug-resistant variants occurred during JNJ-56136379 monotherapy. However, the addition of nucleos(t)ide analogue treatment effectively controlled the viral mutations. This suggests that JNJ-56136379 monotherapy may not be suitable for patients with hepatitis B.

ANTIVIRAL RESEARCH (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

New Perspectives on Development of Curative Strategies for Chronic Hepatitis B

Jordan J. Feld, Anna S. Lok, Fabien Zoulim

Summary: Current therapy for chronic hepatitis B rarely achieves a functional cure, but novel treatments are being developed. Understanding the mechanisms of hepatitis B virus persistence has helped identify new treatment targets and evaluate novel agents in clinical trials. Combining different agents appears to be a promising strategy to reduce viral replication, invigorate immune responses, and induce specific adaptive immune responses.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

添加到收藏夹

Article Infectious Diseases

Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy

Lorin Begre, Anders Boyd, Luisa Salazar-Vizcaya, Franziska Suter-Riniker, Charles Beguelin, Juergen K. Rockstroh, Huldrych F. Guenthard, Alexandra Calmy, Matthias Cavassini, Marcel Stoeckle, Patrick Schmid, Enos Bernasconi, Massimo Levrero, Fabien Zoulim, Gilles Wandeler, Andri Rauch, Swiss HIV Cohort Study SHCS

Summary: In HIV patients with HBsAg loss, qHBsAg levels decline rapidly at the beginning and then show diverse trajectories during long-term tenofovir therapy. In patients without HBsAg loss, qHBsAg levels remain relatively stable over time.

HIV MEDICINE (2023)

添加到收藏夹

Letter Gastroenterology & Hepatology

Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH)

Tangui Barre, David Zucman, Fabienne Marcellin, Clemence Ramier, Camelia Protopopescu, Raphaelle Tardieu, Karine Ory, Dominique Salmon-Ceron, Patrizia Carrieri

JOURNAL OF VIRAL HEPATITIS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Efficacy and safety of the siRNAJNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2btrial

Man-Fung Yuen, Tarik Asselah, Ira M. Jacobson, Maurizia Rossana Brunetto, Harry L. A. Janssen, Tetsuo Takehara, Jin Lin Hou, Thomas N. Kakuda, Tom Lambrecht, Maria Beumont, Ronald Kalmeijer, Carine Guinard-Azadian, Cristiana Mayer, John Jezorwski, Thierry Verbinnen, Oliver Lenz, Umesh Shukla, Michael Biermer

Summary: This study evaluated the efficacy and safety of JNJ-73763989 (JNJ-3989) and JNJ-56136379 (JNJ-6379) in combination with nucleos(t)ide analogues for the treatment of chronic hepatitis B. The results showed that a higher proportion of patients in the JNJ-3989 dual and triple groups met the nucleos(t)ide analogue-stopping criteria at 48 weeks, with good safety profile.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)

添加到收藏夹

Review Microbiology

The Hepatitis B Virus Genotypes E to J: The Overlooked Genotypes

Rayana Maryse Toye, Carmen Luisa Loureiro, Rossana Celeste Jaspe, Fabien Zoulim, Flor Helene Pujol, Isabelle Chemin

Summary: HBV genotypes E to J are understudied and have specific distributions across different regions. Genotype F is the most divergent and has further subgenotypes. There is a lack of data from sub-Saharan Africa and Latin America due to under-representation in clinical and research cohorts.

MICROORGANISMS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Evaluation of the HBV liver reservoir with fine needle aspirates

Barbara Testoni, Armando Andres Roca Suarez, Arianna Battisti, Marie-Laure Plissonnier, Marintha Heil, Thierry Fontanges, Francois Villeret, Yasmina Chouik, Massimo Levrero, Upkar Gill, Patrick Kennedy, Fabien Zoulim

Summary: This study validated the possibility to quantify cccDNA and assess its transcriptional activity in patients with chronic hepatitis B by combining FNA and droplet digital PCR. The use of FNA in clinical trials to evaluate the intrahepatic viral reservoir during the development of new antivirals and immunomodulatory agents is supported.

JHEP REPORTS (2023)

添加到收藏夹

暂无数据

Interplay between hepatitis B virus and TLR2-mediated innate immune responses: Can restoration of TLR2 functions be a new therapeutic option?

期刊

出版社

ELSEVIER SCIENCE BV

关键词

类别

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

评论

主要评分

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

推荐

导出引文

分享论文